Beijing Centergate Technologies (holding) Co., Ltd. (SHE:000931)

China flag China · Delayed Price · Currency is CNY
5.27
+0.10 (1.93%)
Mar 10, 2026, 12:54 PM CST
9.11%
Market Cap 3.89B
Revenue (ttm) 2.48B
Net Income (ttm) 51.45M
Shares Out 753.13M
EPS (ttm) 0.07
PE Ratio 75.68
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,277,274
Average Volume 10,893,508
Open 4.99
Previous Close 5.17
Day's Range 4.99 - 5.28
52-Week Range 3.92 - 5.86
Beta 0.63
RSI 51.93
Earnings Date Apr 18, 2026

About SHE:000931

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of exogenous opioids; Hydrocodone acetaminophen tablets for the treatment of moderate to severe pain; Ambroxol Hydrochloride injection for acute and chron... [Read more]

Sector Healthcare
Founded 1999
Employees 2,267
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000931
Full Company Profile

Financial Performance

In 2024, SHE:000931's revenue was 2.53 billion, an increase of 11.22% compared to the previous year's 2.28 billion. Earnings were 53.59 million, an increase of 10.33%.

Financial Statements

News

There is no news available yet.